Advertisement

  • Get Involved

    Smiling Faces

    Rich Nardiello seeks to bring a smile to children with cancer.

    by Bradley Jones

  • What Is Tumor Mutational Burden?

    The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types.

    by Anna Azvolinsky

  • Pediatric Oncologists Underestimate Needs of Minority Parents

    Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.

    by Marci A. Landsmann

  • Advocacy in Action

    Leaving a Legacy

    Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.

    by Esther Landhuis

  • A Unified Strategy

    A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.

    by Marci A. Landsmann

  • FORWARD LOOK

    Targeted Treatments for Tots

    New law mandates that cancer drugs get tested in kids in clinical trials.

    by Sharon Tregaskis

  • Finding More Targets for CAR-T Cells

    CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.

    by Kendall K. Morgan

  • FORWARD LOOK

    Treatment for Kids’ Brain Tumors Can Cause Hearing Problems

    Severe hearing loss may result in reading and learning difficulties.

    by Esther Landhuis

  • FORWARD LOOK

    For Cancer Researchers, Dogs Offer Clues to Help Kids

    Similarities between cancers create path for studying new treatments.

    by Cameron Walker

  • Forward Look

    Back to School

    Pediatric oncology providers vary in their recommendations on school attendance.

    by Melinda Mahaffey Icden

Advertisement
Advertisement

From the AACR

  • Cervical Cancer Awareness

    The incidence of cervical cancer has been decreasing in the U.S. in recent decades, aided by the implementation of human papillomavirus vaccines.

  • A New President

    As Joe Biden begins his presidency, the cancer research community is watching to see what steps he takes to promote the search for cancer cures.

  • Harnessing Genomic Data

    As AACR Project GENIE marked its fifth anniversary, more than 7,900 individuals are registered to use the public data, and 296 papers have cited the registry.

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR